Xemplar Pharmaceuticals is a contract services company focusing on the development of inhalation products targeting the lungs, nasal passages and buccal cavity. Although formed in July 2002, our expertise and experience is without equal in the CRO industry where this laboratory has successfully met clients’ needs under other names since 1994.